HEADER TRANSFERASE/TRANSFERASE INHIBITOR 11-APR-11 3RHK TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF C-MET KINASE IN COMPLEX TITLE 2 WITH ARQ 197 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HEPATOCYTE GROWTH FACTOR RECEPTOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 1038-1346; COMPND 5 SYNONYM: HGF RECEPTOR, HGF/SF RECEPTOR, PROTO-ONCOGENE C-MET, SCATTER COMPND 6 FACTOR RECEPTOR, SF RECEPTOR, TYROSINE-PROTEIN KINASE MET; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MET; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: CODON-PLUS BL21 (DE3)RIL; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PET; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS KINASE, RECEPTOR TYROSINE KINASE, TRANSFERASE-TRANSFERASE INHIBITOR KEYWDS 2 COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR S.EATHIRAJ,R.PALMA,E.VOLCKOVA,M.HIRSCHI,D.S.FRANCE,M.A.ASHWELL, AUTHOR 2 T.C.CHAN REVDAT 3 21-FEB-24 3RHK 1 REMARK SEQADV REVDAT 2 28-SEP-11 3RHK 1 JRNL VERSN REVDAT 1 27-APR-11 3RHK 0 JRNL AUTH S.EATHIRAJ,R.PALMA,E.VOLCKOVA,M.HIRSCHI,D.S.FRANCE, JRNL AUTH 2 M.A.ASHWELL,T.C.CHAN JRNL TITL DISCOVERY OF A NOVEL MODE OF PROTEIN KINASE INHIBITION JRNL TITL 2 CHARACTERIZED BY THE MECHANISM OF INHIBITION OF HUMAN JRNL TITL 3 MESENCHYMAL-EPITHELIAL TRANSITION FACTOR (C-MET) PROTEIN JRNL TITL 4 AUTOPHOSPHORYLATION BY ARQ 197. JRNL REF J.BIOL.CHEM. V. 286 20666 2011 JRNL REFN ISSN 0021-9258 JRNL PMID 21454604 JRNL DOI 10.1074/JBC.M110.213801 REMARK 2 REMARK 2 RESOLUTION. 1.94 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.94 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 10.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 93.6 REMARK 3 NUMBER OF REFLECTIONS : 48018 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.203 REMARK 3 R VALUE (WORKING SET) : 0.200 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2580 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.94 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.98 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3138 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 84.43 REMARK 3 BIN R VALUE (WORKING SET) : 0.2650 REMARK 3 BIN FREE R VALUE SET COUNT : 154 REMARK 3 BIN FREE R VALUE : 0.3290 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4649 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 56 REMARK 3 SOLVENT ATOMS : 598 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 16.73 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.82000 REMARK 3 B22 (A**2) : -0.65000 REMARK 3 B33 (A**2) : -0.86000 REMARK 3 B12 (A**2) : 0.70000 REMARK 3 B13 (A**2) : 0.81000 REMARK 3 B23 (A**2) : -0.57000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.170 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.118 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.061 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.931 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.886 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 4835 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 6584 ; 1.429 ; 1.972 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 595 ; 5.684 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 194 ;33.021 ;23.299 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 783 ;13.620 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 24 ;14.725 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 745 ; 0.088 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3630 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 2256 ; 0.197 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 3279 ; 0.307 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 433 ; 0.153 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 76 ; 0.168 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 41 ; 0.162 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3052 ; 0.649 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 4805 ; 1.107 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2053 ; 1.541 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1779 ; 2.347 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3RHK COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-APR-11. REMARK 100 THE DEPOSITION ID IS D_1000064940. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 18-JUL-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X29A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.075 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52006 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.940 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 9041.00 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.5 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.03 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.62 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 13% ETHANOL, 12% ETHYLENE GLYCOL, REMARK 280 100MM IMIDAZOLE, PH 8.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1029 REMARK 465 GLY A 1030 REMARK 465 HIS A 1031 REMARK 465 HIS A 1032 REMARK 465 HIS A 1033 REMARK 465 HIS A 1034 REMARK 465 HIS A 1035 REMARK 465 HIS A 1036 REMARK 465 MET A 1037 REMARK 465 GLY A 1038 REMARK 465 ASP A 1039 REMARK 465 SER A 1040 REMARK 465 ASP A 1041 REMARK 465 ILE A 1042 REMARK 465 SER A 1043 REMARK 465 SER A 1044 REMARK 465 PRO A 1045 REMARK 465 LEU A 1046 REMARK 465 LEU A 1047 REMARK 465 GLN A 1048 REMARK 465 MET B 1029 REMARK 465 GLY B 1030 REMARK 465 HIS B 1031 REMARK 465 HIS B 1032 REMARK 465 HIS B 1033 REMARK 465 HIS B 1034 REMARK 465 HIS B 1035 REMARK 465 HIS B 1036 REMARK 465 MET B 1037 REMARK 465 GLY B 1038 REMARK 465 ASP B 1039 REMARK 465 SER B 1040 REMARK 465 ASP B 1041 REMARK 465 ILE B 1042 REMARK 465 SER B 1043 REMARK 465 SER B 1044 REMARK 465 PRO B 1045 REMARK 465 ILE B 1345 REMARK 465 GLY B 1346 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A1064 CG CD OE1 NE2 REMARK 470 GLN A1067 CG CD OE1 NE2 REMARK 470 ASP A1099 CG OD1 OD2 REMARK 470 ASP A1101 CG OD1 OD2 REMARK 470 LYS A1103 CG CD CE NZ REMARK 470 GLN A1123 CG CD OE1 NE2 REMARK 470 ILE A1129 CG1 CG2 CD1 REMARK 470 ILE A1130 CG1 CG2 CD1 REMARK 470 MET A1131 CG SD CE REMARK 470 LYS A1132 CG CD CE NZ REMARK 470 GLU A1172 CG CD OE1 OE2 REMARK 470 GLU A1233 CG CD OE1 OE2 REMARK 470 GLU A1314 CG CD OE1 OE2 REMARK 470 GLU A1325 CG CD OE1 OE2 REMARK 470 ILE A1345 CG1 CG2 CD1 REMARK 470 GLN B1064 CG CD OE1 NE2 REMARK 470 ARG B1086 CG CD NE CZ NH1 NH2 REMARK 470 LYS B1103 CG CD CE NZ REMARK 470 GLU B1127 CG CD OE1 OE2 REMARK 470 GLU B1172 CG CD OE1 OE2 REMARK 470 GLU B1214 CG CD OE1 OE2 REMARK 470 LYS B1215 CG CD CE NZ REMARK 470 LYS B1232 CG CD CE NZ REMARK 470 LYS B1240 CG CD CE NZ REMARK 470 LYS B1323 CG CD CE NZ REMARK 470 MET B1326 CG SD CE REMARK 470 ARG B1336 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O ILE A 1129 O HOH A 383 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 LYS A1132 CA LYS A1132 CB -0.138 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ILE A1130 N - CA - C ANGL. DEV. = -16.9 DEGREES REMARK 500 ARG B1203 NE - CZ - NH1 ANGL. DEV. = 3.9 DEGREES REMARK 500 ARG B1203 NE - CZ - NH2 ANGL. DEV. = -3.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 MET A1131 38.17 72.98 REMARK 500 LYS A1132 26.83 169.48 REMARK 500 ARG A1203 -14.04 80.88 REMARK 500 ASP A1204 42.28 -140.49 REMARK 500 ILE A1345 -56.26 -128.07 REMARK 500 ILE B1129 -70.21 -117.98 REMARK 500 ARG B1203 -10.43 79.69 REMARK 500 ASP B1204 45.50 -147.59 REMARK 500 PHE B1223 -74.13 -80.96 REMARK 500 TYR B1307 -11.29 70.69 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE M97 A 1 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE M97 B 1 DBREF 3RHK A 1038 1346 UNP P08581 MET_HUMAN 1038 1346 DBREF 3RHK B 1038 1346 UNP P08581 MET_HUMAN 1038 1346 SEQADV 3RHK MET A 1029 UNP P08581 EXPRESSION TAG SEQADV 3RHK GLY A 1030 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS A 1031 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS A 1032 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS A 1033 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS A 1034 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS A 1035 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS A 1036 UNP P08581 EXPRESSION TAG SEQADV 3RHK MET A 1037 UNP P08581 EXPRESSION TAG SEQADV 3RHK MET B 1029 UNP P08581 EXPRESSION TAG SEQADV 3RHK GLY B 1030 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS B 1031 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS B 1032 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS B 1033 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS B 1034 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS B 1035 UNP P08581 EXPRESSION TAG SEQADV 3RHK HIS B 1036 UNP P08581 EXPRESSION TAG SEQADV 3RHK MET B 1037 UNP P08581 EXPRESSION TAG SEQRES 1 A 318 MET GLY HIS HIS HIS HIS HIS HIS MET GLY ASP SER ASP SEQRES 2 A 318 ILE SER SER PRO LEU LEU GLN ASN THR VAL HIS ILE ASP SEQRES 3 A 318 LEU SER ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL GLN SEQRES 4 A 318 HIS VAL VAL ILE GLY PRO SER SER LEU ILE VAL HIS PHE SEQRES 5 A 318 ASN GLU VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL TYR SEQRES 6 A 318 HIS GLY THR LEU LEU ASP ASN ASP GLY LYS LYS ILE HIS SEQRES 7 A 318 CYS ALA VAL LYS SER LEU ASN ARG ILE THR ASP ILE GLY SEQRES 8 A 318 GLU VAL SER GLN PHE LEU THR GLU GLY ILE ILE MET LYS SEQRES 9 A 318 ASP PHE SER HIS PRO ASN VAL LEU SER LEU LEU GLY ILE SEQRES 10 A 318 CYS LEU ARG SER GLU GLY SER PRO LEU VAL VAL LEU PRO SEQRES 11 A 318 TYR MET LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG ASN SEQRES 12 A 318 GLU THR HIS ASN PRO THR VAL LYS ASP LEU ILE GLY PHE SEQRES 13 A 318 GLY LEU GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SER SEQRES 14 A 318 LYS LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 15 A 318 MET LEU ASP GLU LYS PHE THR VAL LYS VAL ALA ASP PHE SEQRES 16 A 318 GLY LEU ALA ARG ASP MET TYR ASP LYS GLU TYR TYR SER SEQRES 17 A 318 VAL HIS ASN LYS THR GLY ALA LYS LEU PRO VAL LYS TRP SEQRES 18 A 318 MET ALA LEU GLU SER LEU GLN THR GLN LYS PHE THR THR SEQRES 19 A 318 LYS SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU SEQRES 20 A 318 LEU MET THR ARG GLY ALA PRO PRO TYR PRO ASP VAL ASN SEQRES 21 A 318 THR PHE ASP ILE THR VAL TYR LEU LEU GLN GLY ARG ARG SEQRES 22 A 318 LEU LEU GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR GLU SEQRES 23 A 318 VAL MET LEU LYS CYS TRP HIS PRO LYS ALA GLU MET ARG SEQRES 24 A 318 PRO SER PHE SER GLU LEU VAL SER ARG ILE SER ALA ILE SEQRES 25 A 318 PHE SER THR PHE ILE GLY SEQRES 1 B 318 MET GLY HIS HIS HIS HIS HIS HIS MET GLY ASP SER ASP SEQRES 2 B 318 ILE SER SER PRO LEU LEU GLN ASN THR VAL HIS ILE ASP SEQRES 3 B 318 LEU SER ALA LEU ASN PRO GLU LEU VAL GLN ALA VAL GLN SEQRES 4 B 318 HIS VAL VAL ILE GLY PRO SER SER LEU ILE VAL HIS PHE SEQRES 5 B 318 ASN GLU VAL ILE GLY ARG GLY HIS PHE GLY CYS VAL TYR SEQRES 6 B 318 HIS GLY THR LEU LEU ASP ASN ASP GLY LYS LYS ILE HIS SEQRES 7 B 318 CYS ALA VAL LYS SER LEU ASN ARG ILE THR ASP ILE GLY SEQRES 8 B 318 GLU VAL SER GLN PHE LEU THR GLU GLY ILE ILE MET LYS SEQRES 9 B 318 ASP PHE SER HIS PRO ASN VAL LEU SER LEU LEU GLY ILE SEQRES 10 B 318 CYS LEU ARG SER GLU GLY SER PRO LEU VAL VAL LEU PRO SEQRES 11 B 318 TYR MET LYS HIS GLY ASP LEU ARG ASN PHE ILE ARG ASN SEQRES 12 B 318 GLU THR HIS ASN PRO THR VAL LYS ASP LEU ILE GLY PHE SEQRES 13 B 318 GLY LEU GLN VAL ALA LYS GLY MET LYS TYR LEU ALA SER SEQRES 14 B 318 LYS LYS PHE VAL HIS ARG ASP LEU ALA ALA ARG ASN CYS SEQRES 15 B 318 MET LEU ASP GLU LYS PHE THR VAL LYS VAL ALA ASP PHE SEQRES 16 B 318 GLY LEU ALA ARG ASP MET TYR ASP LYS GLU TYR TYR SER SEQRES 17 B 318 VAL HIS ASN LYS THR GLY ALA LYS LEU PRO VAL LYS TRP SEQRES 18 B 318 MET ALA LEU GLU SER LEU GLN THR GLN LYS PHE THR THR SEQRES 19 B 318 LYS SER ASP VAL TRP SER PHE GLY VAL LEU LEU TRP GLU SEQRES 20 B 318 LEU MET THR ARG GLY ALA PRO PRO TYR PRO ASP VAL ASN SEQRES 21 B 318 THR PHE ASP ILE THR VAL TYR LEU LEU GLN GLY ARG ARG SEQRES 22 B 318 LEU LEU GLN PRO GLU TYR CYS PRO ASP PRO LEU TYR GLU SEQRES 23 B 318 VAL MET LEU LYS CYS TRP HIS PRO LYS ALA GLU MET ARG SEQRES 24 B 318 PRO SER PHE SER GLU LEU VAL SER ARG ILE SER ALA ILE SEQRES 25 B 318 PHE SER THR PHE ILE GLY HET M97 A 1 28 HET M97 B 1 28 HETNAM M97 1-[(3R,4R)-4-(1H-INDOL-3-YL)-2,5-DIOXOPYRROLIDIN-3- HETNAM 2 M97 YL]PYRROLO[3,2,1-IJ]QUINOLINIUM FORMUL 3 M97 2(C23 H16 N3 O2 1+) FORMUL 5 HOH *598(H2 O) HELIX 1 1 ASP A 1054 LEU A 1058 5 5 HELIX 2 2 ASN A 1059 GLN A 1067 1 9 HELIX 3 3 ASP A 1117 GLU A 1127 1 11 HELIX 4 4 ASP A 1164 ASN A 1171 1 8 HELIX 5 5 THR A 1177 LYS A 1198 1 22 HELIX 6 6 ALA A 1206 ARG A 1208 5 3 HELIX 7 7 PRO A 1246 MET A 1250 5 5 HELIX 8 8 GLU A 1253 GLN A 1258 1 6 HELIX 9 9 THR A 1261 THR A 1278 1 18 HELIX 10 10 ASN A 1288 GLN A 1298 1 11 HELIX 11 11 PRO A 1309 TRP A 1320 1 12 HELIX 12 12 LYS A 1323 ARG A 1327 5 5 HELIX 13 13 SER A 1329 THR A 1343 1 15 HELIX 14 14 LEU B 1046 VAL B 1051 5 6 HELIX 15 15 ASP B 1054 LEU B 1058 5 5 HELIX 16 16 ASN B 1059 GLN B 1067 1 9 HELIX 17 17 HIS B 1068 VAL B 1070 5 3 HELIX 18 18 GLY B 1072 SER B 1074 5 3 HELIX 19 19 ASP B 1117 ILE B 1129 1 13 HELIX 20 20 ASP B 1164 ASN B 1171 1 8 HELIX 21 21 THR B 1177 LYS B 1198 1 22 HELIX 22 22 ALA B 1206 ARG B 1208 5 3 HELIX 23 23 PRO B 1246 MET B 1250 5 5 HELIX 24 24 ALA B 1251 GLN B 1258 1 8 HELIX 25 25 THR B 1261 THR B 1278 1 18 HELIX 26 26 ASN B 1288 GLN B 1298 1 11 HELIX 27 27 PRO B 1309 TRP B 1320 1 12 HELIX 28 28 LYS B 1323 ARG B 1327 5 5 HELIX 29 29 SER B 1329 SER B 1342 1 14 SHEET 1 A 3 LEU A1076 ILE A1077 0 SHEET 2 A 3 GLY A1090 LEU A1098 -1 O THR A1096 N ILE A1077 SHEET 3 A 3 VAL A1083 GLY A1087 -1 N GLY A1085 O VAL A1092 SHEET 1 B 5 LEU A1076 ILE A1077 0 SHEET 2 B 5 GLY A1090 LEU A1098 -1 O THR A1096 N ILE A1077 SHEET 3 B 5 LYS A1104 SER A1111 -1 O ILE A1105 N LEU A1097 SHEET 4 B 5 LEU A1154 PRO A1158 -1 O LEU A1157 N ALA A1108 SHEET 5 B 5 GLY A1144 CYS A1146 -1 N GLY A1144 O VAL A1156 SHEET 1 C 2 CYS A1210 LEU A1212 0 SHEET 2 C 2 VAL A1218 VAL A1220 -1 O LYS A1219 N MET A1211 SHEET 1 D 2 SER A1236 VAL A1237 0 SHEET 2 D 2 LYS A1244 LEU A1245 -1 O LEU A1245 N SER A1236 SHEET 1 E 5 LEU B1076 GLY B1087 0 SHEET 2 E 5 GLY B1090 LEU B1098 -1 O VAL B1092 N ILE B1084 SHEET 3 E 5 LYS B1104 SER B1111 -1 O VAL B1109 N TYR B1093 SHEET 4 E 5 LEU B1154 PRO B1158 -1 O LEU B1157 N ALA B1108 SHEET 5 E 5 GLY B1144 CYS B1146 -1 N GLY B1144 O VAL B1156 SHEET 1 F 2 CYS B1210 LEU B1212 0 SHEET 2 F 2 VAL B1218 VAL B1220 -1 O LYS B1219 N MET B1211 SHEET 1 G 2 SER B1236 VAL B1237 0 SHEET 2 G 2 LYS B1244 LEU B1245 -1 O LEU B1245 N SER B1236 SITE 1 AC1 14 HOH A 164 ILE A1084 GLY A1085 PHE A1089 SITE 2 AC1 14 VAL A1092 ALA A1108 LYS A1110 LEU A1140 SITE 3 AC1 14 LEU A1157 PRO A1158 TYR A1159 MET A1160 SITE 4 AC1 14 GLY A1163 PHE A1223 SITE 1 AC2 13 ILE B1084 GLY B1085 PHE B1089 ALA B1108 SITE 2 AC2 13 LYS B1110 LEU B1140 LEU B1157 PRO B1158 SITE 3 AC2 13 TYR B1159 MET B1160 GLY B1163 MET B1211 SITE 4 AC2 13 PHE B1223 CRYST1 53.470 58.670 64.960 88.41 68.10 85.52 P 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.018702 -0.001465 -0.007520 0.00000 SCALE2 0.000000 0.017097 0.000026 0.00000 SCALE3 0.000000 0.000000 0.016591 0.00000